Article Details
Retrieved on: 2018-01-05 20:07:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Renaissance Technologies</b> LLC lifted its position in Ohr Pharmaceuticals by 242.3% in the first quarter. <b>Renaissance Technologies</b> LLC now owns 229,709 shares of the biotechnology company's stock valued at $191,000 after acquiring an additional 162,600 shares during the last quarter.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here